Doxycycline, Temozolomide and Ipilimumab in Melanoma
Clinical trial NCT01590082 · TERMINATED
Trial details
- NCT number
- NCT01590082
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.